Viewing Study NCT01275794


Ignite Creation Date: 2025-12-25 @ 1:33 AM
Ignite Modification Date: 2026-07-19 @ 3:51 AM
Study NCT ID: NCT01275794
Status: COMPLETED
Last Update Posted: 2012-06-04
First Post: 2011-01-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Screening Epidemiological Program on Compensation Evaluation of Diabetes Mellitus Type 2 (DMT2) Patients on Oral Anti-diabetic (OAD) Monotherapy and Physicians Satisfaction of Their Usage
Sponsor: AstraZeneca
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Type 2 Diabetes View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Type 2 Diabetes View